SIENNA BIOPHARMACEUTICALS IN's ticker is SNNAQ and the CUSIP is 82622H108. A total of 24 filers reported holding SIENNA BIOPHARMACEUTICALS IN in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 758,610 | $16,879,000 | 9.55% |
| Partner Investment Management, L.P. | 300,940 | $6,696,000 | 6.35% |
| CLOUGH CAPITAL PARTNERS L P | 751,209 | $16,421,000 | 1.10% |
| Asymmetry Capital Management, L.P. | 41,622 | $926,000 | 1.07% |
| PFM Health Sciences, LP | 1,580,410 | $35,164,000 | 0.69% |
| TimesSquare Capital Management, LLC | 385,200 | $8,571,000 | 0.06% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 21,189 | $471,000 | 0.04% |
| VICTORY CAPITAL MANAGEMENT INC | 458,340 | $10,198,000 | 0.02% |
| FMR LLC | 3,079,684 | $66,250,000 | 0.01% |
| Alyeska Investment Group, L.P. | 50,909 | $1,133,000 | 0.01% |